Digestive tract contrast agent capable of relieving gastrointestinal convulsion and having hypotonic effect

Abstract

The invention discloses a digestive tract contrast agent capable of relieving gastrointestinal convulsion and having hypotonic effect, which is prepared from 50-70 weight parts of barium sulfate dry suspension or compound cardiografin contrast agent and 20-30 weight parts of traditional Chinese medicinal extract. The traditional Chinese medicinal extract is prepared by mixing the following raw materials in parts by weight: 20-30 parts of Corydalis yanhusuo, 10-20 parts of Radix Bupleuri, 20-30 parts of processed Radix Glycyrrhizae, 20-30 parts of Salvia miltiorrhiza, 10-20 parts of Cyperus rotundus, 10-20 parts of Aucklandia lappa, 20-30 parts of Fructus Amomi, 20-30 parts of Evodia rutaecarpa, 10-20 parts of Rhizoma Coptidis, 10-20 parts of Radix Paeoniae Alba, 20-30 parts of Atractylodes macrocephala, 5-10 parts of Radix Codonopsis, 10-20 parts of Bletilla striata, and 5-15 parts of Panax pseudoginseng powder, soaking in water, decocting for 30-40 min, filtering to obtain a filtrate, concentrating the filtrate under reduced pressure, and freeze-drying. The digestive tract contrast agent disclosed by the invention has low adverse side effects and gastrointestinal imaging function, can relieve gastrointestinal convulsion to achieve clinically desired hypotonic effect, and has important value for imaging diagnosis of early gastrointestinal lesions. The digestive tract contrast agent has effects of relieving pain and swelling, dissipating blood stasis, stopping blooding, improving gastrointestinal mucosa microcirculation, promoting gastrointestinal fluid absorption, relieving cardiac ache and gastrointestinal convulsion, and nourishing and treating stomach, intestine, liver, spleen and other organs.

Description

technical field [0001] The present invention relates to a contrast agent. Background technique [0002] In clinical practice, in order to obtain a better effect of gastrointestinal contrast, gastrointestinal hypotonic contrast is needed to better achieve the double contrast of gas and contrast agent. In order to achieve the effect of hypotonicity, it is necessary to relieve the spasm of the digestive tract. Only in this way can the gastrointestinal mucosa be better smeared, small lesions can be displayed, and early diagnosis and early treatment can be achieved. At present, clinically, intramuscular injection of 654-2 is often used to relieve gastrointestinal spasm and hypotonicity before patient examination; however, it often produces adverse reactions such as dry mouth, gastrointestinal numbness, flatulence, etc. Patient's pain, exacerbation of illness. Contents of the invention [0003] In order to solve the above-mentioned technical problems, the present invention pro...

AI Technical Summary

Problems solved by technology

At present, clinically, intramuscular injection of 654-2 is often used to relieve gastrointestinal spasm and hypotonicity before patient examination; however, it often produces adverse reactions such as dry mouth, gastrointestinal numbness, flatulence, etc. patient suffering, aggravation